| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Glucose Intolerance | D018149 | 13 associated lipids |
Total
2
(2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin
Cross Reference
Introduction
To understand associated biological information of (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?
There are no associated biomedical information in the current reference collection.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin
PubChem Associated disorders and diseases
What pathways are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?
There are no associated biomedical information in the current reference collection.
What functions are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with (2s,3r,4r,6e)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid;isp-i;thermozymocidin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Hamada Y et al. | Involvement of de novo ceramide synthesis in pro-inflammatory adipokine secretion and adipocyte-macrophage interaction. | 2014 | J. Nutr. Biochem. | pmid:25283329 |
| Swinnen E et al. | The protein kinase Sch9 is a key regulator of sphingolipid metabolism in Saccharomyces cerevisiae. | 2014 | Mol. Biol. Cell | pmid:24196832 |
| Li W et al. | Endogenous ceramide contributes to the transcytosis of oxLDL across endothelial cells and promotes its subendothelial retention in vascular wall. | 2014 | Oxid Med Cell Longev | pmid:24817993 |
| Correnti JM et al. | Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice. | 2014 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:24742988 |
| Kurek K et al. | Inhibition of ceramide de novo synthesis with myriocin affects lipid metabolism in the liver of rats with streptozotocin-induced type 1 diabetes. | 2014 | Biomed Res Int | pmid:24701589 |
| Curto MÃ et al. | Membrane organization and cell fusion during mating in fission yeast requires multipass membrane protein Prm1. | 2014 | Genetics | pmid:24514900 |
| Yamane-Sando Y et al. | Fpk1/2 kinases regulate cellular sphingoid long-chain base abundance and alter cellular resistance to LCB elevation or depletion. | 2014 | Microbiologyopen | pmid:24510621 |
| Tong M et al. | Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin. | 2014 | Int J Exp Pathol | pmid:24456332 |
| Caretti A et al. | Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis. | 2014 | Biochim. Biophys. Acta | pmid:24141140 |
| Mikłosz A et al. | Effects of inhibition of serine palmitoyltransferase (SPT) and sphingosine kinase 1 (SphK1) on palmitate induced insulin resistance in L6 myotubes. | 2013 | PLoS ONE | pmid:24376889 |